INDB:NASDAQIndependent Bank Corp. Analysis
Data as of 2026-04-10 - not real-time
$79.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Independent Bank Corp. is trading well below its discounted cash‑flow estimate, offering a sizable margin of safety. The stock’s price sits comfortably above the 20‑day moving average but below the 50‑day line, indicating a neutral technical stance, while the MACD histogram remains positive and the RSI is in the upper half of its range, suggesting modest momentum. Recent quarterly results highlighted a 47% revenue surge and an operating margin near 48%, underscoring strong earnings power. The board’s 8.5% dividend increase to $0.64 per share pushes the yield into the low‑3% range, and a payout ratio around 53% points to sustainability. Volume has been tapering, and the 30‑day volatility hovers near 24%, reflecting a moderately choppy market environment. Overall, the combination of undervaluation, robust growth, and a solid dividend profile makes INDB an attractive proposition for income‑focused investors.
From a risk perspective, the stock’s beta slightly exceeds one, indicating modest systematic risk, while the regional banking sector faces medium regulatory headwinds. Nevertheless, the company’s strong capital position, low geographic concentration, and consistent cash‑flow generation mitigate many concerns. The prevailing “Extreme Greed” sentiment in the broader market adds a short‑term boost, but prudent investors should monitor liquidity and sector dynamics. With a clear upside potential of roughly 13% relative to the current price, the stock is well‑positioned for medium‑ to long‑term appreciation.
From a risk perspective, the stock’s beta slightly exceeds one, indicating modest systematic risk, while the regional banking sector faces medium regulatory headwinds. Nevertheless, the company’s strong capital position, low geographic concentration, and consistent cash‑flow generation mitigate many concerns. The prevailing “Extreme Greed” sentiment in the broader market adds a short‑term boost, but prudent investors should monitor liquidity and sector dynamics. With a clear upside potential of roughly 13% relative to the current price, the stock is well‑positioned for medium‑ to long‑term appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Positive MACD histogram indicating bullish momentum
- Dividend increase supports income appeal
- Price near established support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth outpacing peers
- Undervaluation versus DCF fair value
- Sustainable dividend with moderate payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong operating margins and cash‑flow generation
- Long‑term upside from sector recovery
- Consistent dividend policy enhancing total return
Key Metrics & Analysis
Financial Health
Revenue Growth47.10%
Profit Margin25.90%
P/E Ratio18.0
ROE6.25%
ROA0.93%
P/B Ratio1.1
Op. Cash Flow$251.2M
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI60.5
Support$72.66
Resistance$81.80
MA 20$75.96
MA 50$79.10
MA 200$72.40
MACDBullish
VolumeDecreasing
Fear & Greed Index87.21
Valuation
Fair Value$130.22
Target Price$90.00
Upside/Downside12.92%
GradeUndervalued
TypeBlend
Dividend Yield3.15%
Risk Assessment
Beta1.08
Volatility23.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.